Int J Pharm Drug Res 2015;5(1):1-6
At the pathogenic level, PsO and PsA share core inflammatory mechanisms driven by dysregulation of the IL17/IL23 and Tumour Necrosis Factor (TNF)- cytokine axes (14), contributing to keratinocyte hyperproliferation, synovial inflammation, and enthesial disease (1518)
Both equine and rodent models consistently show regenerative effects
GHRP-6 activates GHSR1a using calcium-dependent PKC signaling
Medically reviewed by Eli Luft, PA-C Updated March 2026 Rivas Medical Weight Loss 34 years of physician-led weight management across Maryland, Virginia, and Florida
Guan Z, Li H, Liu R, Cai C, Liu Y, Li J, et al